Clinical Trial Update: Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial

View source ↗

Summary

A chart-review study by MD Anderson Cancer Center investigates outcomes of Chronic Myeloid Leukemia patients who were treated with imatinib outside of a clinica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Chronic Myelogenous Leukemia | Status: RECRUITING